AT1 antagonist modulates activin-like kinase 5 and TGF-β receptor II in the developing kidney

Pediatric Nephrology

Volumn 21, Issue 10, 2006, Pages 1377-1388

  Yim, Hyung Eun ^a   Kim, Mee Kyung ^a   Bae, In Sun ^a   Kim, Ji Hae ^a   Choi, Byung Min ^a   Yoo, Kee Hwan ^b   Hong, Young Sook ^a   Lee, Joo Won ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Angiotensin II type 1 receptor; TGF receptors; Transforming growth factor 1

Indexed keywords

ACTIVIN LIKE KINASE 5; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LOSARTAN; MESSENGER RNA; PHOSPHOTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; KIDNEY DEVELOPMENT; KIDNEY INTERSTITIUM; KIDNEY TUBULE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACTINS; ACTIVIN RECEPTORS, TYPE I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KIDNEY; LOSARTAN; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33747812916     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0197-0     Document Type: Article

References (37)

1. Kriz W, LeHir M (2005) Pathways to nephron loss starting from glomerular diseases - insights from animal models. Kidney Int 67:404-419
2. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC (2003) TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284:F243-F252
3. Basile DP, Hammerman MR (1998) TGF-beta in renal development and renal growth. Miner Electrolyte Metab 24:144-148
4. de Caestecker M (2004) The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 15:1-11
5. Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, Remuzzi G (2002) Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int 61:2066-2077
6. Carey AV, Carey RM, Gomez RA (1992) Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 19(Suppl 2):II168-II175
7. Gonlusen G, Ergin M, Paydas S, Tunali N (2001) The expression of cytoskeletal proteins (alpha-SMA, vimentin, desmin) in kidney tissue: A comparison of fetal, normal kidneys, and glomerulonephritis. Int Urol Nephrol 33:299-305
8. Fan JM, Ng YY, Hill PA, Nikolic Paterson DJ, Mu W, Atkins RC, Lan HY (1999) Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56:1455-1467
9. Chen Y, Lasaitiene D, Gabrielesson BG, Carlsson LM, Billig H, Carlsson B, Marcussen N, Sun XF, Friberg P (2004) Neonatal losartan treatment suppresses renal expression of molecules involved in cell-cell and cell-matrix interactions. J Am Soc Nephrol 15:1232-1243
10. Choi JH, Yoo KH, Cheon HW, Kim KB, Hong YS, Lee JW, Kim SK, Kim CH (2002) Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. Pediatr Res 52:325-332
11. Yoo KH, Wolstenholme JT, Thornhill BA, Chevalier RL (1998) Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am J Hypertens 11:715-722
12. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J (2006) Angiotensin II: A key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21:16-20
13. Tufro-McReddie A, Romani LM, Harris JM, Ferder L, Gomez RA (1995) Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269:F110-F115
14. Choi BM, Yoo KH, Bae IS, Oh MH, Hong YS, Lee JW, Kim SK (2005) Angiotensin converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney. Pediatr Res 57:115-123
15. Nagamatsu T, Hayashi K, Oka T, Suzuki Y (1999) Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis. Eur J Pharmacol 374:93-101
16. Suzuki Y, Lopez-Franco O, Gomez-Garre D, Tejera N, Gomez-Guerrero C, Sugaya T, Bernal R, Blanco J, Ortega L, Egido J (2001) Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: Role of endothelin-1. Am J Pathol 159:1895-1904
17. Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL (2000) Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat. Kidney Int 57:1882-1894
18. Kang NS, Yim HE, Bae IS, Choi JH, Choi BM, Yoo KH, Hong YS, Lee JW, Kim SK (2003) ACE inhibition modulates transforming growth factor-beta receptors in the young rat. Pediatr Nephrol 18:865-871
19. Tso JY, Sun XH, Kao TH, Reece KS, Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502
20. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF (1994) A transforming growth factor beta type I receptor that signals to activate gene expression. Science 263:87-89
21. Choi ME, Kim EG, Huang Q, Ballermann BJ (1993) Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1. Kidney Int 44:948-958
22. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
23. Yoo KH, Cheon HW, Choi BM, Hong YS, Lee JW, Kim SK (1998) Angiotensin converting enzyme inhibition increases apoptosis and bcl-2 expression in the neonatal rat kidney. J Am Soc Nephrol 9:A2613
24. Yoo KH, Choi JH, Kim MK, Hong YS, Lee JW, Kim SK (2000) Angiotensin-converting enzyme inhibition modulates platelet derived growth factors, receptors, and alpha smooth muscle actin expression in the neonatal kidney. J Am Soc Nephrol 11:A385
25. Shin GT, Kim SJ, Ma KA, Kim HS, Kim D (2000) ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans. Am J Kidney Dis 36:894-902
26. Fukuda N, Hu WY, Kubo A, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K (2000) Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells. Am J Hypertens 13:191-198
27. Sun BK, Li C, Lim SW, Choi BS, Lee SH, Kim IS, Kim YS, Bang BK, Yang CW (2005) Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity. Nephron Exp Nephrol 99:e9-e16
28. Wolf G, Ziyadeh FN, Stahl RA (1999) Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J Mol Med 77:556-564
29. Hill C, Logan A, Smith C, Gronbaek H, Flyvbjerg A (2001) Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats. Diabetologia 44:495-500
30. Yoo KH, Wolstenholme JT, Chevalier RL (1997) Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. Pediatr Res 42:588-592
31. Yoo KH, Norwood, El-Daha SS, Yosipiv, Chevalier RL (1997) Regulation of angiotensin II AT1 and AT2 receptors in neonatal ureteral obstruction. Am J Physiol 273:R503-R509
32. Siragy HM (2000) AT1 and AT2 receptors in the kidney: Role in disease and treatment. Am J Kidney Dis 36:S4-S9
33. Jaspard E, Wei L, Alhenc-Gelas F (1993) Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. J Biol Chem 268:9496-9503
34. Yosipiv IV, Dipp S, El-Dahr SS (1997) Role of bradykinin B2 receptors in neonatal kidney growth. J Am Soc Nephrol 8:920-928
35. Cellier E, Mage M, Duchene J, Pecher C, Couture R, Bascands JL, Girolami JP (2003) Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation. Am J Physiol Renal Physiol 284:F282-F292
36. Mariano JM, Montuenga LM, Prentice MA, Cuttitta F, Jakowlew SB (1998) Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis. Int J Dev Biol 42:1125-1136
37. Choi ME, Liu A, Ballermann BJ (1997) Differential expression of transforming growth factor-beta receptors in rat kidney development. Am J Physiol 273:F386-F395